$52.66
0.250.48%
At Close: -
$52.66
00.00%
After Hours: Jul 19, 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Crinetics Pharmaceuticals
CRNXNASDAQ
Crinetics Pharmaceuticals (NASDAQ:CRNX) Stock, Insider Trading Activity
Crinetics Pharmaceuticals: Insider buying and selling updated today.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Crinetics Pharmaceuticals Inc Insiders Doing?
At Crinetics Pharmaceuticals Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 7.88K shares worth $1.22M, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On June 28, 2024, Jeff Knight, the company's CHIEF OPERATING OFFICER sold 956 shares for $44.38 each.
- On June 11, 2024, Stephen Betz, the company's CHIEF SCIENTIFIC OFFICER sold 3K shares for $43.86 each.
- On June 26, 2024, Stephen Betz, the company's CHIEF SCIENTIFIC OFFICER sold 3K shares for $45.37 each.
Ownership Statistics for Crinetics Pharmaceuticals Inc
Institutional Shares Held
44.417M
Institutional Percentage Held
56.3%
| Jul 17, 2024 | Jeff Knight | CHIEF OPERATING OFFICER | -927.00 | $38.80 | -$895.88K | SELL | -1.76% | 51.65K | Jul 15 | View |
| Jul 17, 2024 | Marc Wilson | CFO | 0.00 | $37.51 | -$874.50K | SELL-OPTIONS | 0.00% | 111.09K | Jul 15 | View |
| Jul 12, 2024 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -3.00K | $48.55 | -$145.65K | SELL | -3.68% | 78.61K | Jul 10 | View |
| Jul 09, 2024 | James Hassard | CHIEF COMMERCIAL OFFICER | 0.00 | $31.91 | -$365.25K | SELL-OPTIONS | 0.00% | 29.26K | Jul 05 | View |
| Jul 05, 2024 | Dana Pizzuti | CHIEF MED AND DEV OFFICER | 0.00 | $30.88 | -$402.21K | SELL-OPTIONS | 0.00% | 28.51K | Jul 03 | View |
| Jul 02, 2024 | Marc Wilson | CFO | 0.00 | $26.45 | -$1.10M | SELL-OPTIONS | 0.00% | 111.09K | Jun 28 | View |
| Jun 28, 2024 | Jeff Knight | CHIEF OPERATING OFFICER | -956.00 | $44.38 | -$42.43K | SELL | -1.79% | 52.58K | Jun 26 | View |
| Jun 26, 2024 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -3.00K | $45.37 | -$136.11K | SELL | -3.59% | 80.64K | Jun 25 | View |
| Jun 25, 2024 | Dana Pizzuti | CHIEF MED AND DEV OFFICER | 0.00 | $31.31 | -$273.98K | SELL-OPTIONS | 0.00% | 27.79K | Jun 24 | View |
| Jun 24, 2024 | James Hassard | CHIEF COMMERCIAL OFFICER | 0.00 | $32.20 | -$373.95K | SELL-OPTIONS | 0.00% | 29.26K | Jun 21 | View |
| Jun 11, 2024 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -3.00K | $43.86 | -$131.58K | SELL | -3.46% | 83.64K | Jun 10 | View |
| May 30, 2024 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -3.00K | $47.49 | -$142.47K | SELL | -3.35% | 86.64K | May 28 | View |
| May 14, 2024 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -3.00K | $49.43 | -$148.29K | SELL | -3.24% | 89.64K | May 10 | View |
| May 10, 2024 | Scott Richard Struthers | PRESIDENT & CEO | 0.00 | $29.34 | -$4.31M | SELL-OPTIONS | 0.00% | 258.49K | May 08 | View |
| Apr 17, 2024 | Dana Pizzuti | CHIEF MED AND DEV OFFICER | 0.00 | $30.68 | -$396.46K | SELL-OPTIONS | 0.00% | 27.79K | Apr 15 | View |
| Apr 08, 2024 | Scott Richard Struthers | PRESIDENT & CEO | 0.00 | $29.23 | -$1.63M | SELL-OPTIONS | 0.00% | 238.84K | Apr 04 | View |
| Apr 02, 2024 | Stephanie Okey | DIRECTOR | 0.00 | $32.34 | -$491.57K | SELL-OPTIONS | 0.00% | 6.00K | Mar 28 | View |
| Mar 26, 2024 | Jeff Knight | CHIEF OPERATING OFFICER | -2.36K | $34.14 | -$714.28K | SELL | -4.29% | 52.58K | Mar 22 | View |
| Mar 22, 2024 | Dana Pizzuti | CHIEF MED AND DEV OFFICER | -714.00 | $30.47 | -$421.97K | SELL | -2.51% | 27.79K | Mar 20 | View |
| Mar 22, 2024 | Matthew Fust | DIRECTOR | 0.00 | $32.53 | -$1.39M | SELL-OPTIONS | 0.00% | 18.54K | Mar 20 | View |
| Mar 20, 2024 | Marc Wilson | CFO | -10.93K | $41.17 | -$449.79K | SELL | -8.99% | 110.63K | Mar 18 - Mar 19 | View |
| Jan 26, 2024 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -3.00K | $37.26 | -$111.78K | SELL | -3.93% | 73.30K | Jan 25 | View |
| Jan 12, 2024 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -3.00K | $37.65 | -$112.95K | SELL | -3.78% | 76.30K | Jan 10 | View |
| Jan 04, 2024 | Dana Pizzuti | CHIEF MED AND DEV OFFICER | 0.00 | $25.95 | -$260.33K | SELL-OPTIONS | 0.00% | 5.91K | Jan 03 | View |
| Jan 04, 2024 | Marc Wilson | CFO | 0.00 | $22.38 | -$261.90K | SELL-OPTIONS | 0.00% | 96.06K | Jan 02 | View |
| Dec 27, 2023 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -3.00K | $35.89 | -$107.67K | SELL | -3.65% | 79.30K | Dec 26 | View |
| Dec 22, 2023 | Dana Pizzuti | CHIEF MED AND DEV OFFICER | 0.00 | $25.73 | -$169.43K | SELL-OPTIONS | 0.00% | 5.91K | Dec 21 | View |
| Dec 13, 2023 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -3.00K | $32.87 | -$98.61K | SELL | -3.52% | 82.30K | Dec 11 | View |
| Nov 29, 2023 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -3.00K | $31.84 | -$95.52K | SELL | -3.40% | 85.30K | Nov 27 | View |
| Nov 06, 2023 | Scott Richard Struthers | PRESIDENT & CEO | 0.00 | $19.92 | -$4.26M | SELL-OPTIONS | 0.00% | 225.52K | Nov 02 - Nov 03 | View |
| Nov 03, 2023 | Marc Wilson | CFO | 0.00 | $19.02 | -$194.70K | SELL-OPTIONS | 0.00% | 95.60K | Nov 01 | View |
| Oct 19, 2023 | Seth Alan Krasner | CHIEF MEDICAL OFFICER | 0.00 | $21.00 | -$125.93K | SELL-OPTIONS | 0.00% | 43.21K | Oct 17 | View |
| Jul 13, 2023 | Scott Richard Struthers | PRESIDENT & CEO | -50.00K | $20.21 | -$1.01M | SELL | -6.49% | 720.80K | Jul 11 - Jul 13 | View |
| Jun 21, 2023 | Marc Wilson | CFO | -10.92K | $14.62 | -$431.80K | SELL | -10.30% | 95.16K | Jun 20 | View |
| Jun 21, 2023 | Scott Richard Struthers | PRESIDENT & CEO | -50.00K | $20.81 | -$1.04M | SELL | -6.09% | 770.80K | Jun 16 | View |
| Jun 09, 2023 | Rogerio Coelho Vivaldi | DIRECTOR | 5.00K | $22.06 | $110.30K | BUY | ∞ | 5.00K | Jun 08 | View |
| Apr 05, 2023 | Dana Pizzuti | CHIEF DEVELOPMENT OFFICER | -12.50K | $16.09 | -$201.15K | SELL | -73.53% | 4.50K | Apr 03 - Apr 05 | View |
| Feb 03, 2023 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -3.13K | $19.59 | -$61.24K | SELL | -4.61% | 64.69K | Feb 01 | View |
| Jan 27, 2023 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -8.34K | $21.07 | -$175.64K | SELL | -10.95% | 67.81K | Jan 25 | View |
| Jan 19, 2023 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -3.13K | $18.00 | -$56.27K | SELL | -3.94% | 76.15K | Jan 17 | View |
| Jan 05, 2023 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -3.13K | $18.35 | -$57.36K | SELL | -3.79% | 79.28K | Jan 03 | View |
| Dec 19, 2022 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -3.13K | $16.00 | -$50.02K | SELL | -3.65% | 82.40K | Dec 15 | View |
| Dec 05, 2022 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -3.13K | $17.84 | -$55.77K | SELL | -3.55% | 84.97K | Dec 01 | View |
| Nov 17, 2022 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -3.13K | $18.72 | -$58.52K | SELL | -3.43% | 88.09K | Nov 15 | View |
| Nov 03, 2022 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -3.13K | $18.52 | -$57.89K | SELL | -3.31% | 91.22K | Nov 01 | View |
| Oct 19, 2022 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -3.13K | $17.73 | -$55.42K | SELL | -3.21% | 94.35K | Oct 17 | View |
| Oct 05, 2022 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -3.13K | $19.64 | -$61.39K | SELL | -3.11% | 97.47K | Oct 03 | View |
| Sep 19, 2022 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -4.17K | $21.01 | -$87.57K | SELL | -3.98% | 100.60K | Sep 15 | View |
| Sep 09, 2022 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -1.04K | $21.00 | -$21.88K | SELL | -0.98% | 104.77K | Sep 07 | View |
| Sep 06, 2022 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -1.79K | $14.80 | -$43.39K | SELL | -1.66% | 105.81K | May 20 - Sep 01 | View |
| Jul 29, 2022 | Jeff Knight | CHIEF OPERATING OFFICER | 0.00 | $19.07 | -$3.76K | ACQ/DIS | 0.00% | 4.95K | May 20 - Jul 26 | View |
| Jul 15, 2022 | Matthew Fust | DIRECTOR | 0.00 | $11.20 | -$111.19K | SELL-OPTIONS | 0.00% | 12.54K | Jul 13 | View |
| May 04, 2022 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -3.25K | $20.10 | -$65.25K | SELL | -2.93% | 107.60K | May 02 | View |
| Apr 21, 2022 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -5.66K | $25.81 | -$146.19K | SELL | -4.86% | 110.84K | Apr 18 | View |
| Apr 18, 2022 | PERCEPTIVE ADVISORS LLCPERCEPTIVE LIFE SCIENCES MASTER FUND LTDJOSEPH EDELMAN | 10% OWNER | 157.51K | $22.22 | $3.50M | BUY | 3.05% | 5.32M | Apr 18 | View |
| Apr 15, 2022 | Scott Richard Struthers | PRESIDENT & CEO | -138.64K | $26.83 | -$3.72M | SELL | -14.45% | 820.80K | Apr 13 | View |
| Apr 07, 2022 | Scott Richard Struthers | PRESIDENT & CEO | -21.36K | $25.34 | -$541.22K | SELL | -2.18% | 959.45K | Apr 05 | View |
| Apr 06, 2022 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -9.00K | $23.97 | -$215.76K | SELL | -7.17% | 116.51K | Apr 04 | View |
| Apr 01, 2022 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -8.33K | $21.43 | -$178.47K | SELL | -6.22% | 125.51K | Mar 31 - Apr 01 | View |
| Mar 17, 2022 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -3.12K | $18.94 | -$59.15K | SELL | -2.28% | 133.84K | Mar 15 | View |
| Mar 02, 2022 | Ajay Madan | CHIEF DEVELOPMENT OFFICER | 22.95K | $19.88 | $178.92K | GRANT | 14.90% | 177.00K | Feb 28 - Mar 01 | View |
| Mar 02, 2022 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | 13.38K | $19.73 | -$61.62K | GRANT | 10.82% | 136.96K | Feb 28 - Mar 01 | View |
| Feb 17, 2022 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -3.12K | $18.64 | -$58.21K | SELL | -2.46% | 123.58K | Feb 15 | View |
| Feb 09, 2022 | Ajay Madan | CHIEF DEVELOPMENT OFFICER | -13.41K | $17.83 | -$239.08K | SELL | -7.23% | 172.04K | Feb 07 | View |
| Feb 03, 2022 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -3.12K | $18.79 | -$58.68K | SELL | -2.41% | 126.71K | Feb 01 | View |
| Jan 21, 2022 | Seth Alan Krasner | CHIEF MEDICAL OFFICER | 0.00 | $16.61 | -$61.61K | SELL-OPTIONS | 0.00% | 8.31K | Jan 19 | View |
| Jan 20, 2022 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -4.17K | $23.29 | -$97.07K | SELL | -3.13% | 128.88K | Jan 18 | View |
| Jan 06, 2022 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -7.17K | $28.02 | -$200.85K | SELL | -5.11% | 133.04K | Jan 03 | View |
| Dec 30, 2021 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -3.00K | $27.95 | -$83.85K | SELL | -2.09% | 140.21K | Dec 28 | View |
| Dec 17, 2021 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -5.67K | $24.14 | -$136.83K | SELL | -3.81% | 143.21K | Dec 15 | View |
| Dec 03, 2021 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -5.67K | $27.38 | -$155.19K | SELL | -3.67% | 148.88K | Dec 01 | View |
| Nov 17, 2021 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -7.17K | $27.01 | -$193.57K | SELL | -4.43% | 154.55K | Nov 15 - Nov 16 | View |
| Nov 09, 2021 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -16.50K | $28.06 | -$463.04K | SELL | -9.26% | 161.72K | Nov 05 - Nov 08 | View |
| Nov 03, 2021 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -5.67K | $24.79 | -$140.51K | SELL | -3.08% | 178.22K | Nov 01 | View |
| Nov 03, 2021 | Matthew Fust | DIRECTOR | 0.00 | $13.71 | -$211.22K | SELL-OPTIONS | 0.00% | 12.54K | Nov 01 | View |
| Oct 28, 2021 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -3.00K | $24.00 | -$71.99K | SELL | -1.61% | 183.88K | Oct 27 | View |
| Oct 25, 2021 | Stephen Betz | CHIEF SCIENTIFIC OFFICER | -1.04K | $21.10 | -$21.98K | SELL | -0.55% | 186.88K | Oct 21 | View |
| Oct 25, 2021 | PERCEPTIVE ADVISORS LLCPERCEPTIVE LIFE SCIENCES MASTER FUND LTDJOSEPH EDELMAN | 10% OWNER | 1.20M | $19.80 | $23.76M | BUY | 30.28% | 5.16M | Oct 25 | View |
| Sep 09, 2021 | Matthew Fust | DIRECTOR | 0.00 | $13.71 | -$142.63K | SELL-OPTIONS | 0.00% | 12.54K | Sep 08 | View |
| Sep 09, 2021 | Scott Richard Struthers | PRESIDENT & CEO | -30.00K | $25.00 | -$750.00K | SELL | -2.97% | 980.80K | Sep 07 | View |
| Jul 27, 2021 | Matthew Fust | DIRECTOR | 0.00 | $10.75 | -$88.40K | SELL-OPTIONS | 0.00% | 12.54K | Jul 26 | View |
| Jul 20, 2021 | Matthew Fust | DIRECTOR | 0.00 | $10.71 | -$87.95K | SELL-OPTIONS | 0.00% | 12.54K | Jul 19 | View |
| Jul 13, 2021 | Matthew Fust | DIRECTOR | 0.00 | $11.31 | -$94.00K | SELL-OPTIONS | 0.00% | 12.54K | Jul 12 | View |
| Apr 09, 2021 | PERCEPTIVE ADVISORS LLCPERCEPTIVE LIFE SCIENCES MASTER FUND LTDJOSEPH EDELMAN | 10% OWNER | 304.14K | $16.44 | $5.00M | BUY | 8.31% | 3.96M | Apr 08 | View |
| Dec 04, 2020 | Scott Richard Struthers | — | 5.00K | $13.00 | $65.00K | PURCHASE | 5.05% | 104.00K | Dec 02 - Dec 03 | View |
| Jul 17, 2020 | Scott Richard Struthers | — | -35.00K | $14.88 | -$520.83K | SELL | -3.41% | 990.80K | Jul 15 - Jul 16 | View |
| Apr 20, 2020 | PERCEPTIVE ADVISORS LLCPERCEPTIVE LIFE SCIENCES MASTER FUND LTDJOSEPH EDELMAN | — | 1.07M | $14.00 | $15.00M | PURCHASE | 41.40% | 3.66M | Apr 17 | View |
| Apr 17, 2020 | Vivo Capital VIII LLCVivo Capital Fund VIII LPVivo Capital Surplus Fund VIII LP | — | -330.60K | $15.45 | -$5.11M | SELL | -52.54% | 298.63K | Apr 15 - Apr 17 | View |
| Apr 07, 2020 | Vivo Capital VIII LLCVivo Capital Fund VIII LPVivo Capital Surplus Fund VIII LP | — | -306.12K | $13.81 | -$4.23M | SELL | -47.47% | 338.74K | Apr 03 - Apr 07 | View |
| Mar 11, 2020 | Vivo Capital VIII LLCVivo Capital Fund VIII LPVivo Capital Surplus Fund VIII LPVivo Opportunity LLCVivo Opportunity Fund LP | — | -528.00 | $19.50 | -$10.30K | SELL | -0.31% | 168.16K | Mar 09 | View |
| Feb 11, 2020 | Vivo Capital VIII LLCVivo Capital Fund VIII LPVivo Capital Surplus Fund VIII LPVivo Opportunity LLCVivo Opportunity Fund LP | — | -13.46K | $21.66 | -$291.59K | SELL | -7.41% | 168.30K | Feb 07 - Feb 10 | View |
| Feb 06, 2020 | Vivo Capital VIII LLCVivo Capital Fund VIII LPVivo Capital Surplus Fund VIII LPVivo Opportunity LLCVivo Opportunity Fund LP | — | -13.46K | $22.80 | -$306.89K | SELL | -7.00% | 178.82K | Feb 04 | View |
| Jan 31, 2020 | Vivo Capital VIII LLCVivo Capital Fund VIII LPVivo Capital Surplus Fund VIII LPVivo Opportunity LLCVivo Opportunity Fund LP | — | -26.92K | $22.07 | -$594.16K | SELL | -12.45% | 189.34K | Jan 29 - Jan 31 | View |
| Dec 18, 2019 | Matthew Fust | DIRECTOR | 0.00 | $12.21 | -$72.06K | SELL-OPTIONS | 0.00% | 12.54K | Dec 16 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.